Literature DB >> 12111363

Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve.

Maria Schäfers1, Christine Schmidt, Carola Vogel, Klaus V Toyka, Claudia Sommer.   

Abstract

Proinflammatory cytokines like tumor necrosis factor-alpha (TNF) contribute to Wallerian degeneration by enhancing the adhesion of leukocytes to the endothelium through increased expression of adhesion molecules. Here we studied the influence of TNF and TNF receptors (TNFR) on intercellular adhesion molecule-1 (ICAM-1) and macrophage influx following chronic constrictive injury (CCI) in mice by three different paradigms: (1) C57BL/Wld mice with delayed TNF up-regulation, (2) in vivo inhibition of TNFR1 and TNFR2 by neutralizing antibodies, and (3) three different types of mice with a genetic deficiency for TNFR. C57BL/Wld mice with a delayed macrophage influx had a delayed increase of ICAM-1 compared to control mice. In vivo inhibition of both TNFR significantly impaired macrophage recruitment; however, treatment with anti-TNFR1 antibodies increased endoneurial ICAM-1 expression. In TNFR1 and TNFR1+2, but not TNFR2-deficient mice, endoneurial ICAM-1 expression was significantly reduced, which correlated with prolonged Wallerian degeneration in TNFR1-deficient mice 2 weeks after CCI. Our data support the hypothesis that TNF regulates the expression of ICAM-1 predominantly through TNFR1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111363     DOI: 10.1007/s00401-002-0541-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling.

Authors:  Anna Dellarole; Paul Morton; Roberta Brambilla; Winston Walters; Spencer Summers; Danielle Bernardes; Mariagrazia Grilli; John R Bethea
Journal:  Brain Behav Immun       Date:  2014-06-02       Impact factor: 7.217

2.  Nuclear factor-kappaB activation in axons and Schwann cells in experimental sciatic nerve injury and its role in modulating axon regeneration: studies with etanercept.

Authors:  Darrell Smith; Christopher Tweed; Paul Fernyhough; Gordon W Glazner
Journal:  J Neuropathol Exp Neurol       Date:  2009-06       Impact factor: 3.685

Review 3.  TNFalpha: a trigger of autonomic dysfunction.

Authors:  Gerlinda E Hermann; Richard C Rogers
Journal:  Neuroscientist       Date:  2007-10-02       Impact factor: 7.519

4.  TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1.

Authors:  Jessy J Alexander; Alexander Jacob; Patrick Cunningham; Lauren Hensley; Richard J Quigg
Journal:  Neurochem Int       Date:  2007-08-17       Impact factor: 3.921

5.  Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis.

Authors:  Peng Lv; Shelley Chireyath Paul; Yanjv Xiao; Shiquan Liu; Hesheng Luo
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 6.  Beta secretase activity in peripheral nerve regeneration.

Authors:  Carolyn Tallon; Mohamed H Farah
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

7.  Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression.

Authors:  Silke Griepke; Emilie Grupe; Jes Sanddal Lindholt; Elizabeth Hvitfeldt Fuglsang; Lasse Bach Steffensen; Hans Christian Beck; Mia Dupont Larsen; Sissel Karoline Bang-Møller; Martin Overgaard; Lars Melholt Rasmussen; Kate Lykke Lambertsen; Jane Stubbe
Journal:  Front Cardiovasc Med       Date:  2022-09-16

Review 8.  A New Venue of TNF Targeting.

Authors:  Sophie Steeland; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Int J Mol Sci       Date:  2018-05-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.